The economics of stone disease

Noah E. Canvasser; Peter Alken; Michael Lipkin; Stephen Y. Nakada; Hiren S. Sodha; Abdulkadir Tepeler; Yair Lotan

doi:10.1007/s00345-017-2003-y

The economics of stone disease

Noah E. Canvasser, Peter Alken, Michael Lipkin, Stephen Y. Nakada, Hiren S. Sodha, Abdulkadir Tepeler, Yair Lotan

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Abstract

The rising prevalence of kidney stone disease is associated with significant costs to healthcare systems worldwide. This is in part due to direct procedural and medical management costs, as well as indirect costs to health systems, patients, and families. A number of manuscripts evaulating the economics of stone disease have been published since the 2008s International Consultation on Stone Disease. These highlight costs associated with stone disease, including acute management, surgical management, and medical management. This work hopes to highlight optimization in care by reducing inefficient treatments and maximizing cost-efficient preventative strategies.

Original language	English (US)
Pages (from-to)	1-9
Number of pages	9
Journal	World Journal of Urology
DOIs	https://doi.org/10.1007/s00345-017-2003-y
State	Accepted/In press - Jan 20 2017

Keywords

Cost
Economics
Kidney stones
Nephrolithiasis

ASJC Scopus subject areas

Urology

Access to Document

10.1007/s00345-017-2003-y

Cite this

@article{8f33c200c1ce49efbea11725ac7cf599,

title = "The economics of stone disease",

abstract = "The rising prevalence of kidney stone disease is associated with significant costs to healthcare systems worldwide. This is in part due to direct procedural and medical management costs, as well as indirect costs to health systems, patients, and families. A number of manuscripts evaulating the economics of stone disease have been published since the 2008s International Consultation on Stone Disease. These highlight costs associated with stone disease, including acute management, surgical management, and medical management. This work hopes to highlight optimization in care by reducing inefficient treatments and maximizing cost-efficient preventative strategies.",

keywords = "Cost, Economics, Kidney stones, Nephrolithiasis",

author = "Canvasser, {Noah E.} and Peter Alken and Michael Lipkin and Nakada, {Stephen Y.} and Sodha, {Hiren S.} and Abdulkadir Tepeler and Yair Lotan",

year = "2017",

month = jan,

day = "20",

doi = "10.1007/s00345-017-2003-y",

language = "English (US)",

pages = "1--9",

journal = "World Journal of Urology",

issn = "0724-4983",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - The economics of stone disease

AU - Canvasser, Noah E.

AU - Alken, Peter

AU - Lipkin, Michael

AU - Nakada, Stephen Y.

AU - Sodha, Hiren S.

AU - Tepeler, Abdulkadir

AU - Lotan, Yair

PY - 2017/1/20

Y1 - 2017/1/20

N2 - The rising prevalence of kidney stone disease is associated with significant costs to healthcare systems worldwide. This is in part due to direct procedural and medical management costs, as well as indirect costs to health systems, patients, and families. A number of manuscripts evaulating the economics of stone disease have been published since the 2008s International Consultation on Stone Disease. These highlight costs associated with stone disease, including acute management, surgical management, and medical management. This work hopes to highlight optimization in care by reducing inefficient treatments and maximizing cost-efficient preventative strategies.

AB - The rising prevalence of kidney stone disease is associated with significant costs to healthcare systems worldwide. This is in part due to direct procedural and medical management costs, as well as indirect costs to health systems, patients, and families. A number of manuscripts evaulating the economics of stone disease have been published since the 2008s International Consultation on Stone Disease. These highlight costs associated with stone disease, including acute management, surgical management, and medical management. This work hopes to highlight optimization in care by reducing inefficient treatments and maximizing cost-efficient preventative strategies.

KW - Cost

KW - Economics

KW - Kidney stones

KW - Nephrolithiasis

UR - http://www.scopus.com/inward/record.url?scp=85009844482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009844482&partnerID=8YFLogxK

U2 - 10.1007/s00345-017-2003-y

DO - 10.1007/s00345-017-2003-y

M3 - Article

C2 - 28108799

AN - SCOPUS:85009844482

SN - 0724-4983

SP - 1

EP - 9

JO - World Journal of Urology

JF - World Journal of Urology

ER -

The economics of stone disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this